Data / Form D filings / Slayback Pharma Ltd Liability Co
Slayback Pharma Ltd Liability Co: Form D filing
Slayback Pharma Ltd Liability Co, a pharmaceuticals company in Princeton Junction, NJ, filed a Form D with the SEC in 2017. The latest, on January 19, 2017, reports $35 million sold of a $35 million offering to 4 investors.
Find out what Slayback Pharma Ltd Liability Co does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 37 SLAYBACK DRIVE, Princeton Junction, NJ, 08550
- Phone
- (609) 477-0142
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1695256
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 19, 2017 | New notice | $35,000,000 | $35,000,000 | $0 | 4 | Dec 29, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Neel J. Varshney | Director | |
| Ajay Singh | Executive Officer, Director | |
| Ali J. Satvat | Director | |
| Gyan J. Singh | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jan 16, 2017 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Slayback Pharma Ltd Liability Co reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.